Protalix Biotherapeutics, Inc. (PLX)
1.80
-0.03
(-1.64%)
USD |
NYAM |
Dec 12, 10:45
Protalix Biotherapeutics Research and Development Expense (TTM): 18.06M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| GlucoTrack, Inc. | 9.885M |
| PAVmed, Inc. | 3.472M |
| AIM ImmunoTech, Inc. | 3.826M |
| Perspective Therapeutics, Inc. | 61.22M |
| Armata Pharmaceuticals, Inc. | 26.10M |